Life Sciences Executive – Alzheimer’s Advisory Board Member
About the Company
Alzheimer's disease and cognitive decline affect far more than memory. They can change a person's independence, relationships, identity, and the lives of entire families. Alzheimer's Treatment Centers of America (ATCA) was created to challenge the idea that cognitive decline should simply be diagnosed, managed, and accepted. ATCA is actually using Artificial Intelligence (AI) as part of its approach to patient care. Its patented AI platform works alongside personalized precision medicine to help identify and address more than 100 potential root causes of cognitive decline, using patient-specific clinical data to help guide individualized treatment strategies. The early results are compelling. In an observational study of ATCA's Alzheimer's protocol, 80% of participants following the protocol showed no further decline in their mild cognitive impairment. ATCA is bringing together clinical innovation, artificial intelligence, precision medicine, and multidisciplinary care to rethink how Alzheimer's disease, dementia, and related cognitive disorders are approached.
About the Role
ATCA is seeking accomplished pharmaceutical, biotechnology, and life sciences executives to join its Advisory Board and bring relevant industry experience to the development of its cognitive care business. This role is for senior leaders who understand how healthcare innovation is evaluated, communicated, and adopted. We welcome experience in commercialization, medical affairs, business development, clinical development, or executive leadership, particularly where it relates to neurological conditions or complex patient needs. Advisory Board Members will help leadership evaluate its positioning within the broader Alzheimer’s and brain health landscape. Your experience will inform discussions about clinical evidence, medical engagement, potential industry relationships, and the business considerations involved in bringing a differentiated care approach to more patients. This part-time, remote strategic advisory role requires approximately 1 - 2 hours per month.
Key Responsibilities
Advise leadership on relevant developments in the Alzheimer’s and brain health landscape Provide perspective on evaluating and communicating clinical evidence Share insight on medical engagement and the factors influencing adoption of healthcare innovation Help evaluate potential relationships with life sciences and healthcare organizations Advise on positioning and commercialization using relevant industry experience Introduce relevant senior industry and medical relationships where appropriate Participate in periodic virtual Advisory Board meetings and strategic discussions
Preferred Qualifications
Substantial executive leadership experience in pharmaceuticals, biotechnology, or life sciences Current or former CEOs, senior commercial executives, medical affairs leaders, clinical development leaders, or business development executives Experience bringing healthcare innovation to market or leading industry partnerships Understanding of clinical evidence, medical engagement, and healthcare commercialization Relevant experience in neurology, Alzheimer’s disease, cognitive health, or other complex care areas is welcome Ability to apply industry experience to the practical needs of a growing healthcare business Interest in Alzheimer’s disease, brain health, cognitive decline, precision medicine, or healthcare innovation Why Join ATCA? Bring your life sciences experience to a healthcare business focused on personalized Alzheimer’s and cognitive care. Advisors will help ATCA evaluate its industry position, engage relevant medical and business relationships, and make informed commercialization decisions.